1 insider bought shares over the last 90 days, the latest by Adam Davey, filed 05 Aug 2026.
Every trade that managers of Painchek Ltd disclose to ASX is tracked on this page. 4 insiders have disclosed 4 filings since 18 October 2025.
The flow runs one way only: 2 insiders bought (2 purchases) and nobody sold on the market. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 2 senior executives.
The last insider purchase was made public on 5 August 2026, 74 days ago.
Compared with its exchange (2,222 companies, median 3 filings), a count of 4 filings is above the norm. Over the whole record (from 2026), the tally stands at 2 purchases and no sales.
This summary is built from ASX disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
FY ended June 2024 · cache
4 of 4 declarations
Painchek Ltd is a company listed on the XASX, focused on developing technological solutions for pain management. It emphasizes innovation in the healthcare and patient care sectors.